Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2005
10/26/2005EP1137426B1 Breast cancer treatment using natural plant essential oils
10/26/2005EP1109559B1 Inhibition of pathogenic processes related to tissue trauma
10/26/2005EP1087778B1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
10/26/2005EP1063999B1 Epiallopregnanolone in the treatment of cns disorders
10/26/2005EP1035842B1 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION
10/26/2005EP1034793B1 Preventives/remedies for glaucoma
10/26/2005EP0951289B1 Use of mycobacterium vaccae for treating chronic fatigue syndrome
10/26/2005EP0762880B1 Retroviral protease inhibitor combinations
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688599A Use of dipeptidyl peptidase IV inhibitor
10/26/2005CN1688589A Beta-lactamase inhibitor prodrug
10/26/2005CN1688586A Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors
10/26/2005CN1688585A Antitumoral analogs of lamellarins
10/26/2005CN1688580A Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
10/26/2005CN1688578A Phosphodiesterase 4 inhibitors
10/26/2005CN1688577A Triazaspiro [5.5] undecane derivatives and drugs comprising the same as the active ingredient
10/26/2005CN1688572A Piperidinyl targeting compounds that selectively bind integrins
10/26/2005CN1688566A Remedies
10/26/2005CN1688549A Compound having TGF-beta inhibitory activity and medicinal composition containing the same
10/26/2005CN1688547A A-'7-halo-2-quino (xa-) linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
10/26/2005CN1688540A Novel vinyl carboxylic acid derivatives and their therapeutical use
10/26/2005CN1688532A Composition based on substituted 1, 3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1688365A Therapeutic use
10/26/2005CN1688302A Use of hydroxyoleic acid and similar compounds in the production of medicaments
10/26/2005CN1688299A Suppression of cytotoxic protein conformers
10/26/2005CN1688291A Immediate release dosage forms containing solid drug dispersions
10/26/2005CN1688193A Mixed compositions for controlling parasitic insects
10/26/2005CN1224627C Modified factor VIII
10/26/2005CN1224624C 1, 8-naphthyridin-2 (1H)-one derivatives
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224614C Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/26/2005CN1224612C Acetylenic sulfonamide thiol TACE inhibitors
10/26/2005CN1224598C Naphthalene derivatives
10/26/2005CN1224423C Pharmaceutical composition improved in peroral absorbability
10/26/2005CN1224418C Biological preparation containing marine active substance and use thereof
10/26/2005CN1224391C Endoparasiticidal combination
10/26/2005CN1224389C The use of scopolamine salts
10/26/2005CN1224388C Modified prodrug forms of ap/amp
10/25/2005US6958411 Antitumor agent; viricide
10/25/2005US6958396 8-{4-[3-(5-fluoro-1H-indol-3-YL)-Propyl]-Piperazin-1-YL}-2-methyl-4H-Benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine D2 receptor and the serotonin reuptake site
10/25/2005US6958389 Preparing a tetraphenylporphyrin derivative (V) comprising demetalizing a tetraphenylporphyrin derivative of the formula (IV) to obtain a tetraphenylporphyrin derivative represented by the formula (V):
10/25/2005US6958387 Human serpin polypeptides
10/25/2005US6958357 Central nervous system disorders; antiallergens; respiratory system disorders
10/25/2005US6958353 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958351 NMDA NR2B antagonists for treatment
10/25/2005US6958349 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/25/2005US6958344 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/25/2005US6958343 Treating psoriasis, a disease in which angiogenesis is associated with raised CXCR2 chemokine levels, or COPD.
10/25/2005US6958336 Anticancer agents; immunosuppressants; antiallergens; antiinflammatory agents
10/25/2005US6958333 N'-(isoindolino[3,2-b]perhydro-1,3-oxazin-5-on-9-yl)-N-(pyridin-2-yl) urea, for example; cyclin-dependent kinase inhibitors; colon cancer treatment
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005US6958319 Stability and longer shelf life; bortezomib N-(2-pyrazine)carbonyl-L-phenylalanine-L-leucine boronic acid
10/25/2005CA2332461C New benzenesulfonamide derivatives, their method of preparation and the pharmaceutical compositions containing them
10/25/2005CA2331053C Compositions and methods for treating conditions responsive to estrogen
10/25/2005CA2304657C Treatment of conduct disorder
10/25/2005CA2266468C Preparation of 1-butyl-4-piperidinylmethylamine
10/25/2005CA2229045C Use of muteins of wild-type cytokines as immunogens
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/21/2005CA2504582A1 Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer
10/21/2005CA2504401A1 Drug delivery systems for the prevention of neointimal hyperlasia
10/20/2005WO2005097995A1 CANCER THERAPY VIA THE INHIBITION OF Skp-2 EXPRESSION
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005097782A1 Piperidine derivative
10/20/2005WO2005097764A1 Thiazole derivative
10/20/2005WO2005097738A1 Novel sulfonamide derivative
10/20/2005WO2005097204A1 Preventives/remedies for cancer
10/20/2005WO2005097170A1 Angiogenesis promoter and angiogenic therapy
10/20/2005WO2005097152A1 Turmeric extract-containing composition having improved caking capacity
10/20/2005WO2005097118A1 Aldosterone receptor antagonists
10/20/2005WO2005097097A1 Agent for controlling cholesterol homeostasis-associated gene transcription activity mediated by fxr activation
10/20/2005US20050234248 Method of producing preparations rich in tocotrienol
10/20/2005US20050234245 Estrogen receptor modulators
10/20/2005US20050234225 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression
10/20/2005US20050234223 Drug candidate compounds such as H3 receptor inverse agonists can be screened more easily and efficiently
10/20/2005US20050234130 Medicament for therapeutic treatment of vascular disease
10/20/2005US20050234126 Amide derivatives as inhibitors of the enzymatic activity of renin
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005US20050234117 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level
10/20/2005US20050234116 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia
10/20/2005US20050234094 Inhibition of protein kinases with piridinylimidazoles
10/20/2005US20050234090 Modulators of chemokine receptor activity
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234083 Diamino-pyrimidines and their use as angiogenesis inhibitors
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234079 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy] benzyl]thiazolidine-2,4-dione potassium salt
10/20/2005US20050234077 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234051 5-Substituted 2-aryl-4 pyrimidinones
10/20/2005US20050234048 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005US20050234039 Substituted lactams as inhibitors of Abeta protein production
10/20/2005US20050234035 New salts
10/20/2005US20050234029 Compounds
10/20/2005US20050234017 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
10/20/2005US20050234011 Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/20/2005US20050234008 Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
1 ... 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 ... 1564